| Opioid OD | Opioid-related ED visit/hospitalization | All cause ED visit/hospitalization |
---|---|---|---|
 | Number with event (%) | ||
 Treatment setting | |||
  Outpatient | 32 (1.4%) | 297 (12.7%) | 1446 (61.9%) |
  Residential | 24 (2.5%) | 147 (15.4%) | 717 (74.9%) |
 | Adjusted HR (95% CI) | ||
 Treatment setting | |||
  Outpatient | ref | ref | – |
  Residential | 1.39 (0.73–2.64) | 1.02 (0.80–1.29) | – |
  Outpatient < 14 days post-admission | – | – | Ref |
  Residential < 14 days post-admission | – | – | 2.48 (1.98–3.11) |
  Outpatient 14 + days post-admission | – | – | Ref |
  Residential 14 + days post-admission | – | – | 1.25 (1.12–1.41) |
 Gender | |||
  Male | Ref | Ref | Ref |
  Female | 0.84 (0.48–1.49) | 1.44 (1.19–1.75) | 1.36 (1.24–1.48) |
 Race | |||
  White | Ref | Ref | Ref |
  Black or African American | 0.83 (0.10–6.89) | 0.53 (0.20–1.42) | 1.29 (0.92–1.81) |
  Alaska Native/American Indian | 1.62 (0.39–6.83) | 1.38 (0.86–2.20) | 1.13 (0.89–1.43) |
  Other single race | 1.92 (0.58–6.30) | 1.59 (1.01–2.51) | 1.08 (0.85–1.36) |
  Two or more races | 1.16 (0.60–2.25) | 0.91 (0.72–1.16) | 1.04 (0.93–1.17) |
 Age | |||
  18–29 | Ref | Ref | Ref |
  30–39 | 1.57 (0.80–3.07) | 0.92 (0.73–1.15) | 0.98 (0.89–1.08) |
  40 +  | 2.02 (1.02–3.98) | 0.98 (0.77–1.26) | 1.09 (0.97–1.22) |
 Elixhauser score | 1.03 (0.99–1.07) | 1.02 (1.00–1.03) | 1.00 (1.00–1.01) |
 Substances used | |||
  Heroin | 1.77 (0.54–5.76) | 1.41 (0.96–2.08) | 0.92 (0.78–1.08) |
  Rx opioid | 0.71 (0.29–1.74) | 0.82 (0.61–1.11) | 1.16 (1.01–1.33) |
  Methadone | 0.97 (0.13–7.34) | 0.55 (0.24–1.26) | 0.78 (0.58–1.06) |
  Alcohol | 1.62 (0.89–2.95) | 0.94 (0.73–1.22) | 1.02 (0.91–1.14) |
  Stimulant | 0.43 (0.22–0.85) | 0.90 (0.73–1.11) | 1.12 (1.02–1.24) |
 Injection opioid use | 1.54 (0.77–3.08) | 1.44 (1.14–1.81) | 1.25 (1.13–1.39) |
 Opioid use frequency | |||
  Not in last month | Ref | Ref | Ref |
  Use in past week-month | 3.63 (1.33–9.95) | 1.38 (1.00–1.89) | 1.06 (0.92–1.21) |
  Daily | 2.22 (0.84–5.89) | 1.39 (1.05–1.83) | 1.04 (0.93–1.17) |
 Prior inpatient medically supervised withdrawal | 1.44 (0.75–2.77) | 1.23 (0.94–1.59) | 1.11 (0.98–1.26) |
 MOUD use | 0.45 (0.23–0.89) | 0.96 (0.78–1.20) | 0.84 (0.76–0.93) |
 Prior all-cause ED/hospitalization | 0.76 (0.41–1.40) | 1.33 (1.08–1.64) | 1.83 (1.67–2.01) |
 Prior opioid-related ED/hospitalization | 2.16 (1.03–4.52) | 1.72 (1.31–2.26) | 0.94 (0.81–1.09) |